• Species-Specific Roles of SHH and FGF Signaling in Penile De

  2026-07-29

  This study identifies how differential expression of Shh, Fgf10, and Fgfr2 shapes distinct mechanisms of prepuce and urethral groove formation in mice versus guinea pigs. The findings refine our understanding of mammalian penile development and provide a more accurate model for investigating human congenital malformations.

• Immune Rejuvenation Mitigates Alzheimer’s Pathology in Mice

  2026-07-29

  Sun et al. demonstrate that transplantation of young bone marrow into aged Alzheimer’s disease (AD) model mice rejuvenates peripheral immune cells, restoring gene expression profiles and reducing AD-like neuropathology. This work highlights immune system rejuvenation as a promising therapeutic concept for AD and refines the understanding of immunosenescence in neurodegenerative disease progression.

• Lypressin Acetate: Strategic Leverage in Translational Resea

  2026-07-28

  This article explores the mechanistic, experimental, and translational value of lypressin acetate for researchers advancing vasopressin analogues, bridging endocrine and antiviral domains. It integrates peer-reviewed evidence, protocol parameters, and strategic guidance, positioning APExBIO’s Lypressin acetate as a gold-standard tool for precision and innovation.

• Pertussis Toxin: Optimizing Immune Modulation Workflows

  2026-07-28

  Pertussis toxin is a gold-standard AB5-type protein exotoxin for dissecting immune response pathways and signal transduction in translational immunology. This guide delivers actionable protocol enhancements, troubleshooting strategies, and experimental insights for maximizing data reliability in dendritic cell and T cell studies.

• Anti Reverse Cap Analog (ARCA): Enabling High-Fidelity Synth

  2026-07-27

  Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, empowers next-generation synthetic mRNA applications with precision capping and translational efficiency. This article uniquely dissects ARCA's impact on cell fate engineering and mRNA therapeutics research.

• Anisomycin as a JNK Agonist: Practical Workflows and Trouble

  2026-07-27

  Anisomycin, a precision JNK agonist from APExBIO, enables robust apoptosis induction and cell signaling studies across cancer and neurobiology models. This article distills assay-ready workflows, experimental insights, and expert troubleshooting guidance drawn from recent advances and benchmarked protocols.

• Protease Inhibitor Cocktail: Precision in Lipid Droplet Assa

  2026-07-26

  Safeguard protein complexes and drive reproducible results in lipid droplet metabolism research with the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus). This ready-to-use solution from APExBIO empowers reliable protein extraction and enables advanced studies into DFCP1-ATGL regulatory mechanisms.

• Anti Reverse Cap Analog (ARCA): Unlocking Reliable mRNA Tran

  2026-07-25

  Explore how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, optimizes mRNA capping for robust translation in cell reprogramming and synthetic biology. This article uniquely connects high-efficiency capping to breakthrough applications in stem cell differentiation, distinguishing ARCA's role beyond conventional workflows.

• PDHA1 Succinylation Drives Immune Escape in Cholangiocarcino

  2026-07-24

  This study reveals that succinylation of PDHA1 at lysine 83 in cholangiocarcinoma alters metabolic flux, leading to α-ketoglutaric acid accumulation and impaired macrophage antigen presentation. The findings underscore the therapeutic potential of targeting PDHA1 succinylation to enhance chemotherapy efficacy and modulate tumor-immune interactions.

• Dextran Sulfate Sodium Salt: Elevating DSS Colitis Models

  2026-07-24

  Dextran sulfate sodium salt (MW 35000-45000) powers robust, translational mouse models of inflammatory bowel disease by reliably inducing acute and chronic intestinal inflammation. This guide details advanced workflows, protocol enhancements, and troubleshooting insights to maximize experimental reproducibility and leverage cutting-edge mechanistic findings for ulcerative colitis research.

• Ellagic Acid as a Precision Probe for Senescence and CK2 Sig

  2026-07-23

  Explore how Ellagic acid, a selective CK2 inhibitor, is advancing cancer biology and senescence assay strategies. This article uniquely connects mechanistic insight with next-generation senolytic discovery, offering new perspectives beyond standard protocols.

• CRTC-CREB Axis Senses Proteotoxic Stress via Proteasome Inhi

  2026-07-23

  This study uncovers the CRTC-CREB axis as a conserved transcriptional sensor that responds to proteasome inhibition and oxidative stress in Drosophila. Activation of CREB via ROS/JNK signaling upon proteasome β5 subunit inhibitor treatment reveals new avenues for research on protein aggregation, neurodegeneration, and aging-related diseases.

• Alda 1: Advanced ALDH2 Activation for Cardiac Stress Adaptat

  2026-07-22

  Explore how Alda 1, a potent ALDH2 activator, enables new strategies for cardioprotection in ischemia and radiation-induced skin injury. This article delivers unique mechanistic insights and protocol guidance, extending beyond standard cardiac regeneration content.

• LMO2-LDB1 Complex Drives AML Progression via Transcriptional

  2026-07-22

  This study uncovers the pivotal role of the LMO2/LDB1 protein complex in promoting acute myeloid leukemia (AML) cell proliferation and survival. By integrating genetic, proteomic, and transcriptomic analyses, the researchers establish LDB1 as an oncogenic driver in AML, offering new directions for targeted interventions.

• Technical Application of Angiotensin I/II (1-5) Peptide in R

  2026-07-21

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide for modeling blood pressure regulation and aldosterone signaling within renin-angiotensin system research. It is strictly suited to cardiovascular and renal pathways and should not be used for unrelated signaling or peptide experiments.

16192 records 1/1080 page Next 12345 下5页 Last page